Skip to content

Prospective multicenter study of robot-assisted stereotactic guided thermotherapy for focal drug-resistant epilepsy

Prospective multicenter study of robot-assisted stereotactic guided thermotherapy for focal drug-resistant epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060974
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

RF-TC group:RF-TC
LITT group:LITT
Resection group:Resection surgery

Sponsors

Sanbo Brain Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Patients aged 3-70 years. 2) The patient met the diagnostic criteria of drug-refractory epilepsy in ILAE guidelines. 3) The patient had a definite epileptogenic focus after preoperative comprehensive evaluation, which was in line with the indications of stereotactic radiofrequency thermocoagulation, robot-assisted stereotactic laser interstitial thermotherapy or traditional resection surgery. 4) The patient himself/herself and/or his/her guardian have positive demands for surgical treatment and sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1) The patient had poor compliance and was unable to cooperate with all the tests and examinations included in the study; 2) The patient could not identify the epileptogenic focus or had multiple epileptogenic focuses after comprehensive evaluation, and was not suitable for the operation included in the study; 3) The patient had surgical contraindications and could not tolerate epilepsy surgery; 4) He had undergone other epilepsy surgery in the past.

Design outcomes

Primary

MeasureTime frame
Information related to surgery (duration of surgery, amount of blood loss, complications, and cost of surgery);Neurological impairment (NIHSS scale);Seizures Condition;Electroencephalogram (discharge index, etc.);Status of antiepileptic drugs taken (type and dose);Post-operative MRI;

Countries

China

Contacts

Public ContactGuoming Luan
lgmmishu@163.com13801103741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026